ClinicalTrials.gg
TerminatedNCT03463902GesttDCSUpdated Mar 28, 2024

Transcranial Direct Current Stimulation (tDCS) to Improve Gesture Control

An interventional study of left IFG anodal and left IFG cathodal in Schizophrenia and Related Disorders, sponsored by University of Bern. Terminated at 1 site in Switzerland. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-28.

Sponsored by University of Bern · Not applicable, Interventional, and Treatment

Why this study was terminated
Recruitment failed to enroll sufficient number of patients
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The majority of schizophrenia patients is impaired in hand gesture performance, which contributes to poor functional outcome and poor communication skills. The left inferior frontal gyrus (IFG) and the left inferior parietal lobe (IPL) are key nodes of the gesture network, which is less active in patients with schizophrenia. Here, the investigators test single 10 min sessions of tDCS known to either enhance or inhibit local brain activity for app. 1 hour. The investigators aim to determine, which protocol may improve gesture performance in patients and healthy controls. This is a randomized, double-blind, cross-over, placebo-controlled single-center trial in 20 patients with schizophrenia spectrum disorders and 20 healthy controls. Gesture performance will be tested immediately after each tDCS session, which are separated by 24 hours. Results of this study will inform larger interventional trials comparing 2 tDCS protocols with repeated administration.

Read the detailed description

Schizophrenia is associated with poor social functioning, which is perturbed by deficits in social interaction including nonverbal communication. The use of hand gestures is critical for nonverbal communication, but the majority of schizophrenia patients has severe gesture impairments. Today no intervention may ameliorate gesture impairments.

Patients with gesture impairments have altered structure and function of the gesture network, particularly the left inferior frontal gyrus (IFG) and also the left inferior parietal lobe (IPL). Noninvasive brain stimulation techniques may alter local brain function. Transcranial direct current stimulation (tDCS) for 10 mins is a very safe method to alter brain states locally for a period of 1-2 hours. Indeed, facilitatory stimulation of the left frontal cortex by tDCS demonstrated improved gesture perception and interpretation in healthy subjects. Furthermore, patients with apraxia identified gestures better after facilitatory tDCS over the left inferior parietal lobe (IPL). Thus, the investigators hypothesize that local changes of brain activity within the gesture network would change gesture performance.Particularly, anodal (facilitatory) stimulation of the left IFG would improve gesture performance. The investigators will test single sessions of tDCS in healthy subjects and schizophrenia patients. If one of the protocols proves to have superior effects, this result will help to plan interventional trials targeting social interaction deficits in schizophrenia.

The aim of the study is to determine the effect of one 10 min session of anodal tDCS over the left IFG on gesture performance compared to three active and one placebo tDCS sessions. This is a randomized, double-blind, cross-over, placebo-controlled single-center trial in 20 patients with schizophrenia spectrum disorders and 20 healthy controls. After baseline assessment of gesture performance, participants will receive one 10 min tDCS protocol each day, immediately followed by assessments of gesture performance and dexterity. Gesture performance will be measured with video recorded Test of Upper Limb Apraxia, which is rated blindly according to a manual. Active comparisons are cathodal tDCS over left IFG, anodal tDCS over left IPL and cathodal tDCS over left IPL.

02

Conditions studied

  • Schizophrenia and Related Disorders

Keywords

  • Gesture
  • tDCS
  • schizophrenia
  • nonverbal communication
03

In context

Schizophrenia

3,563 studies on the registry are indexed under Schizophrenia; 491 are open to participants now.

This study's enrollment of 32 is below the median of 71 across 2,944 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

University of Bern is the lead sponsor of 209 studies on the registry; 47 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Right handed according to the Edinburgh Handedness Inventory
  • Ability and willingness to participate in the study
  • Ability to provide written
  • Informed Consent as documented by signature (Appendix Informed Consent Form)
  • Spent majority of childhood/adolescence in Switzerland
  • Patients: schizophrenia spectrum disorder according to

Exclusion criteria

Exclusion Criteria:

  • Women who are pregnant or breast feeding
  • Metal objects on or in the body (e.g. grenade splinter, cardiac pacemaker, vessel clips, metal prostheses, coil, cochlear implants, hearing aid, tooth implant)
  • Tattoos on head, neck or shoulder in close proximity to the electrode placement
  • Current skin problems on the scalp, eg. bruises or open wounds
  • History of neurosurgery, any severe head wounds, history of neurologic disorders impacting gesture, e.g. Parkinson's disease, stroke, multiple sclerosis
  • Active drug addiction except nicotine
  • Known contact allergies
  • Controls: first-degree relatives with schizophrenia spectrum disorders
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    left IFG anodal

    2 mA Stimulation of 10 min, anodal electrode over left IFG, cathodal electrode over right IFG, 30 sec ramp to start and 30 sec ramp to stop

    Device: left IFG anodal

  • Active comparator
    left IFG cathodal

    2 mA Stimulation of 10 min, cathodal electrode over left IFG, anodal electrode over right IFG, 30 sec ramp to start and 30 sec ramp to stop

    Device: left IFG cathodal

  • Active comparator
    left IPL anodal

    2 mA Stimulation of 10 min, anodal electrode over left IPL, cathodal electrode over right IPL, 30 sec ramp to start and 30 sec ramp to stop

    Device: left IPL anodal

  • Active comparator
    left IPL cathodal

    2 mA Stimulation of 10 min, anodal electrode over left IFG, cathodal electrode over right IFG, 30 sec ramp to start and 30 sec ramp to stop

    Device: left IPL cathodal

  • Placebo comparator
    Placebo

    anodal electrode over left IFG, cathodal electrode over right IFG, stimulation only during 30 sec ramp at beginning and end of 10 min

    Device: Placebo

Interventions

  • Deviceleft IFG anodal

    Single session of transcranial direct current stimulation (tDCS) over left IFG anodal stimulation 2 mA Stimulation of 10 min, anodal electrode over left IFG, cathodal electrode over right IFG, 30 sec ramp to start and 30 sec ramp to stop

  • Deviceleft IFG cathodal

    Single session of transcranial direct current stimulation (tDCS) over left IFG cathodal stimulation 2 mA Stimulation of 10 min, cathodal electrode over left IFG, anodal electrode over right IFG, 30 sec ramp to start and 30 sec ramp to stop

  • Deviceleft IPL anodal

    Single session of transcranial direct current stimulation (tDCS) over left IPL anodal stimulation 2 mA Stimulation of 10 min, anodal electrode over left IPL, cathodal electrode over right IPL, 30 sec ramp to start and 30 sec ramp to stop

  • Deviceleft IPL cathodal

    Single session of transcranial direct current stimulation (tDCS) over left IPL cathodal stimulation 2 mA Stimulation of 10 min, anodal electrode over left IFG, cathodal electrode over right IFG, 30 sec ramp to start and 30 sec ramp to stop

  • DevicePlacebo

    Single session of placebo tDCS over left IFG 10 min duration, 30 sec ramp during start and end

06

What researchers measure

Primary outcomes

  1. Test of Upper Limb Apraxia

    Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment and group

    Time frame: 10 mins after baseline assessment

  2. Test of Upper Limb Apraxia

    Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment and group

    Time frame: 10 mins after tDCS intervention left IFG anodal

  3. Test of Upper Limb Apraxia

    Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment and group

    Time frame: 10 mins after tDCS intervention left IFG cathodal

  4. Test of Upper Limb Apraxia

    Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment and group

    Time frame: 10 mins after tDCS intervention left IPL anodal

  5. Test of Upper Limb Apraxia

    Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment and group

    Time frame: 10 mins after tDCS intervention left IPL cathodal

  6. Test of Upper Limb Apraxia

    Standardized gesture performance test, video recorded and rated according to manual by a rater blind to treatment and group

    Time frame: 10 mins after tDCS intervention with placebo

Secondary outcomes

  1. Coin Rotation

    Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns

    Time frame: 20 mins after baseline assessment

  2. Coin Rotation

    Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns

    Time frame: 20 mins after tDCS intervention left IFG anodal

  3. Coin Rotation

    Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns

    Time frame: 20 mins after tDCS intervention left IFG cathodal

  4. Coin Rotation

    Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns

    Time frame: 20 mins after tDCS intervention left IPL anodal

  5. Coin Rotation

    Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns

    Time frame: 20 mins after tDCS intervention left IPL cathodal

  6. Coin Rotation

    Test of dexterity, 3 trials of 10s to rotate a .5 SFr coin between thumb, index and middle finger, video recorded, rated blindly according to number of coin half turns

    Time frame: 20 mins after tDCS intervention with placebo

07

Study locations

1 site
  • University Hospital of Psychiatry
    Bern, 3000, Switzerland
08

References and documents

Individual participant data

Plan to share: No — The investigators do not plan to share the data, because they cannot anonymize the video data sufficiently

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03463902
Lead sponsor
University of Bern
Responsible party
Sponsor
First posted
Mar 13, 2018
Start date
Jan 29, 2018
Primary completion
Sep 25, 2023
Completion
Mar 22, 2024
Last update
Mar 28, 2024

Study contacts

Sebastian Walther, MD
principal investigator · University of Bern, University Hospital of Psychiatry

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion